Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

The genome of the Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) was mapped with cosmid and phage genomic libraries from the BC-1 cell line. Its nucleotide sequence was determined except for a 3-kb region at the right end of the genome that was refractory to cloning. The BC-1 KSHV genome consists of a 140.5-kb-long unique coding region flanked by multiple G + C-rich 801-bp terminal repeat sequences. A genomic duplication that apparently arose in the parental tumor is present in this cell culture-derived strain. At least 81 ORFs, including 66 with homology to herpesvirus saimiri ORFs, and 5 internal repeat regions are present in the long unique region. The virus encodes homologs to complement-binding proteins, three cytokines (two macrophage inflammatory proteins and interleukin 6), dihydrofolate reductase, bcl-2, interferon regulatory factors, interleukin 8 receptor, neural cell adhesion molecule-like adhesin, and a D-type cyclin, as well as viral structural and metabolic proteins. Terminal repeat analysis of virus DNA from a KS lesion suggests a monoclonal expansion of KSHV in the KS tumor.

[1]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.

[2]  C. Boshoff,et al.  Cyclin encoded by KS herpesvirus , 1996, Nature.

[3]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[4]  G. Gaidano,et al.  Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. , 1996, Leukemia.

[5]  J. Lieberman,et al.  The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients , 1996, The Journal of experimental medicine.

[6]  W. Zhong,et al.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Terao,et al.  In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses. , 1996, Virology.

[8]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[9]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. , 1996, Archives of internal medicine.

[10]  E Tom,et al.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.

[11]  E. Cesarman,et al.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.

[12]  R. Desrosiers,et al.  Association of the viral oncoprotein STP-C488 with cellular ras , 1995, Molecular and cellular biology.

[13]  E. E. Max,et al.  Infection of human endothelial cells with Epstein-Barr virus , 1995, The Journal of experimental medicine.

[14]  E. Cesarman,et al.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.

[15]  P. Biberfeld,et al.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma , 1995, Nature Medicine.

[16]  E. Telford,et al.  The DNA sequence of equine herpesvirus 2. , 1995, Journal of molecular biology.

[17]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[18]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[19]  C. Fisher,et al.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma , 1995, The Lancet.

[20]  V. Calvez,et al.  Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma , 1995, The Lancet.

[21]  T. Shenk,et al.  Viruses and apoptosis. , 1995, Current opinion in genetics & development.

[22]  M. David.  Transcription factors in interferon signaling. , 1995, Pharmacology & therapeutics.

[23]  R. Mertelsmann,et al.  BCL-2 induction is part of the strategy of Epstein-Barr virus. , 1994, Leukemia & lymphoma.

[24]  E. Reed,et al.  Naturally processed cytokine-derived peptide bound to HLA-class II molecules. , 1993, Journal of immunology.

[25]  V. Beral,et al.  Epidemiologic clues to the etiology of Kaposi's sarcoma. , 1993, AIDS.

[26]  G. Peters,et al.  Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. , 1993, Oncogene.

[27]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[28]  J. Tappero,et al.  Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy , 1993 .

[29]  Albrecht,et al.  Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.

[30]  R. Mertelsmann,et al.  Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. , 1992, Blood.

[31]  R. Gallo,et al.  Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's Sarcoma , 1992, Immunological reviews.

[32]  R. Honess,et al.  Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins , 1992, Nature.

[33]  R. Desrosiers,et al.  Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488 , 1991, Journal of virology.

[34]  V. V. Santen,et al.  Characterization of the bovine herpesvirus 4 major immediate-early transcript. , 1991 .

[35]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[36]  G. Tosato,et al.  Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells , 1990, Journal of virology.

[37]  B. Barrell,et al.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. , 1990, Current topics in microbiology and immunology.

[38]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[39]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[40]  A. Bankier,et al.  Random cloning and sequencing by the M13/dideoxynucleotide chain termination method. , 1987, Methods in enzymology.

[41]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[42]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[43]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[44]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[45]  P. Deininger.  Random subcloning of sonicated DNA: application to shotgun DNA sequence analysis. , 1983, Analytical biochemistry.

[46]  D. Hanahan,et al.  [24] Plasmid screening at high colony density , 1983 .

[47]  W. D. Benton,et al.  Screening lambdagt recombinant clones by hybridization to single plaques in situ. , 1977, Science.